Iftikhar Kullo, MD., has been invited to serve on the National Advisory Council on Human Genome Research (NACHGR) of the National Institutes of Health (NIH), by the Hon’ble Xavier Becerra, Secretary of the Department of Health and Human Services (DHHS), for a term beginning immediately and ending September 30, 2024. The Council advises the DHHS, the NIH, and the National Human Genome Research Institute (NHGRI), on genetics, genomic research, training and programs related to the human genome initiative.
Dr. Kullo is a professor of medicine at Mayo Clinic College of Medicine and Science, and a consultant in the Department of Cardiovascular Medicine and the Gonda Vascular Center. His research is focused on the genetic basis of coronary heart disease, as well as the implementation of genomic medicine. Dr. Kullo heads the Atherosclerosis and Lipid Genomics Laboratory, chairs the Cardiovascular Genomics Task Force and directs the Early Atherosclerosis and Familial Hypercholesterolemia Clinics at Mayo Clinic. He has been continuously funded by the NIH since 2003 and is a Principal Investigator in the NHGRI’s eMERGE and PRIMED consortia.
“I am honored to serve on the National Advisory Council on Human Genome Research,” Dr. Kullo says. “Genomics is transforming biomedical research and I’m excited to have the opportunity to advise on the discovery and implementation aspects of genomic medicine to improve outcomes for our patients.”
Read more about his research on the genetic basis of high cholesterol in adults and genetic risk of heart disease in diverse populations.
Read more stories about advances in individualized medicine.
Register to get weekly updates from the Mayo Clinic Center for Individualized Medicine blog.
Tags: center for individualized medicine, DNA Testing, Dr. Iftikhar Kullo, gene sequencing, Genetics, genomic medicine, genomics, individualized medicine, medical research, Multi-omics, National Institutes of Health, Precision Medicine